Regression of Fibroadenoma In Response To Centchroman Therapy- A Randomized Control Trial

Journal Title: Stanley Medical Journal - Year 2017, Vol 4, Issue 2

Abstract

Context Fibroadenoma is a common cause of breast lump in young girls. Nearly 10–15 % of lesions regress spontaneously over the period of 6 to 60 months Aim The aim of study was to investigate the role of Centchroman in regression of fibroadenoma in comparison to natural observation in persons who is willing for observation instead of excisional biopsy (enucleation) between 18 -30 yrs old.Settings and Design The study was carried out at the outpatient clinic of Department of General Surgery, Govt. Stanley medical College from November 2014 to April 2015 Study design Randomized control trial Material 80 Patients Methods and Material Patients aged ≤30 years with fibroadenoma were included. Patients with fibroadenoma equal to or larger than 3 cm and with polycystic ovarian disease were excluded. Patients were randomized in two groups. Patients in active therapy arm were prescribed Centchroman 30 mg on alternative days for 12 weeks, and another group was observed without any intervention (control group). Patients were followed at weeks 4, 8, 12, and 24 . USG Breast done at 0 days, 12 and 24 weeks for both groups to assess volume regression Statistical analysis used The collected data was analysed with SPSS 16.0 version.To describe about the data descriptive statistics frequency analysis, percentage analysis were used for categorical variables and the mean & S.D were used for continuous variables. To find the significant difference between the bivariate samples in Independent groups (Study group & Control group) Unpaired sample t-test was used. For the repeated measures (Volume zero day ,12th week & 24th week ) the Repeated measures of ANOVA with adjustment for multiple comparisons to control the type I error, the Bonferroni test was used.To find the significance in categorical data Chi-Square test was used. Results At the end of 12 weeks follow- up, 38 (95%) patients showed decrease in size in study as compared to 11( 27%) in control group. At the end of 24 weeks follow-up, 15 (37.5%) patients showed complete disappearance compared to 5 (12.5%) patients in control group. 22 (55%) patients showed decrease in size as compared to 6 (15%) patients in control group. Conclusions Centchroman therapy in Fibroadenoma treatment showed satistifically significant regression of volume in Patients more than 30 yrs old and young patients (<30 yrs) with suspicious histology, recurrence, family h/o carcinoma breast, anxiousness and no response to conservative management. Key-words: Fibroadenoma (FA), Centchroman, Polycystic ovarian disease

Authors and Affiliations

Balamurugan C, Vignesh M, Princess Beulah D, Sabarimalai P

Keywords

Related Articles

BARDET–BEIDL SYNDROME WITH RICKETS

Bardet-Biedl syndrome (BBS) is a rare ciliopathic genetically heterogenous disorder with wide spectrum of clinical features. They present with varied signs and symptoms among affected individuals, even among members of...

OCULAR CYSTICERCOSIS  A CASE REPORT

Cysticercosis is caused by the metacestode or a larval stage of Taenia solium,the pork tapeworm.The clinical syndromes caused by t.solium are categorised as either cysticercosis or taeniasis.

A STUDY TO DETERMINE THE ASSOCIATION BETWEEN THE KELLGREN-LAWRENCE GRADE AND WOMAC SCORE IN POPULATION WITH OSTEOARTHRITIC KNEE

Objective:To determine the association between Kellgren-Lawrence radiological grade and WOMAC scores among population with osteoarthritic knee. Study design: This is a cross sectional quantitative prospective study desig...

SUBCUTANEOUS FAT NECROSIS OF NEWBORN WITH ASYMPTOMATIC HYPERCALCEMIA.

A 9 day old male baby born of consanguinous marriage postmaturely by labour naturale was admitted for birth asphyxia and meconium aspiration in NICU for a week developed multiple erythematous nodules over the back, butto...

Emphysematous Pyelonephritis -Pattern Of Clinical Presentation And Outcome: Single Center Study

Context: Emphysematous pyelonephritis(EPN) is a life threatening necrotizing infection of the kidney. It is commonly seen in diabetic patients and continues to be a major cause for morbidity and mortality. Treatment opti...

Download PDF file
  • EP ID EP217431
  • DOI -
  • Views 88
  • Downloads 0

How To Cite

Balamurugan C, Vignesh M, Princess Beulah D, Sabarimalai P (2017). Regression of Fibroadenoma In Response To Centchroman Therapy- A Randomized Control Trial. Stanley Medical Journal, 4(2), 19-22. https://europub.co.uk/articles/-A-217431